Home > Income Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Revenue

    Back to Income Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹6,658 Cr₹5,986 Cr₹5,855 Cr₹6,056 Cr₹5,049 Cr

What is the latest Revenue of EMCURE PHARMACEUTICALS ?

The latest Revenue ratio of EMCURE PHARMACEUTICALS is ₹6,658 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹6,658 Cr
Mar2023₹5,986 Cr
Mar2022₹5,855 Cr
Mar2021₹6,056 Cr
Mar2020₹5,049 Cr

How is Revenue of EMCURE PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2024 ₹6,658 Cr
11.23
Mar2023 ₹5,986 Cr
2.23
Mar2022 ₹5,855 Cr
-3.32
Mar2021 ₹6,056 Cr
19.96
Mar2020 ₹5,049 Cr -

Compare Revenue of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹25,725.6 Cr 0.9% 3.2% 0.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,872.0 Cr 0.7% 2.8% 7.9% Stock Analytics
DIVIS LABORATORIES ₹177,609.0 Cr -0.8% 3.7% 48.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,277.0 Cr 3.4% 11.2% 17.9% Stock Analytics
CIPLA ₹119,184.0 Cr -0.2% -0.1% -1.9% Stock Analytics
DR REDDYS LABORATORIES ₹105,116.0 Cr 0.6% -5.2% -4.9% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

0.9%

3.2%

0.1%

SENSEX

-0.1%

1%

1.8%


You may also like the below Video Courses